Cargando…

Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial

BACKGROUND AND AIMS: The clinical efficacy of fecal microbiota transplantation (FMT) in patients with non-alcoholic fatty liver disease (NAFLD) and the variant effects of FMT on lean and obese NAFLD patients remain elusive. Our study aimed to determine the clinical efficacy and safety of FMT for pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Lanfeng, Deng, Zhiliang, Luo, Wenhui, He, Xingxiang, Chen, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289257/ https://www.ncbi.nlm.nih.gov/pubmed/35860380 http://dx.doi.org/10.3389/fcimb.2022.759306

Ejemplares similares

Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
por: Wang, Jieyi, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Neurological Disorders
por: Vendrik, Karuna E. W., et al.
Publicado: (2020)

The Super-Donor Phenomenon in Fecal Microbiota Transplantation
por: Wilson, Brooke C., et al.
Publicado: (2019)

Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
por: Bokoliya, Suresh C., et al.
Publicado: (2021)

Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials
por: Li, Yapeng, et al.
Publicado: (2022)

Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application
por: Halaweish, Hossam F., et al.
Publicado: (2022)

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis
por: Gai, Xiaowei, et al.
Publicado: (2021)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
por: Zhang, Shuo, et al.
Publicado: (2022)

The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice
por: He, Yan, et al.
Publicado: (2019)

Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study
por: Wu, Zezhen, et al.
Publicado: (2023)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Alters the Outcome of Hepatitis B Virus Infection in Mice
por: Wang, Junzhong, et al.
Publicado: (2022)

Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
por: Zhang, Fengwei, et al.
Publicado: (2022)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Future Directions in Reducing Gastrointestinal Disorders in Children With ASD Using Fecal Microbiota Transplantation
por: Żebrowska, Paulina, et al.
Publicado: (2021)

The Fecal Microbiota Transplantation: A Remarkable Clinical Therapy for Slow Transit Constipation in Future
por: Liu, Jiafei, et al.
Publicado: (2021)

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
por: Chen, Justin, et al.
Publicado: (2021)

Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression
por: Cai, Ting, et al.
Publicado: (2022)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis
por: Chen, Qiongyun, et al.
Publicado: (2023)

Fecal microbiota transplantation in a rodent model of short bowel syndrome: A therapeutic approach?
por: Fourati, Salma, et al.
Publicado: (2023)

Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
por: Van Dingenen, Lena, et al.
Publicado: (2023)

Altered Fecal Microbiota Composition in Older Adults With Frailty
por: Xu, YuShuang, et al.
Publicado: (2021)

Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
por: Wang, Hui, et al.
Publicado: (2020)

Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease
por: Zou, Biao, et al.
Publicado: (2023)

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Innes, Andrew J., et al.
Publicado: (2021)

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
por: Pan, Xiongfeng, et al.
Publicado: (2021)

Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments
por: Chen, Xiaoxia, et al.
Publicado: (2023)

Fecal microbiota transplantation inhibited neuroinflammation of traumatic brain injury in mice via regulating the gut–brain axis
por: Hu, Xuezhen, et al.
Publicado: (2023)

Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids
por: Sun, QinMei, et al.
Publicado: (2022)

Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder
por: Zhou, Yumei, et al.
Publicado: (2020)

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease
por: Wang, Xinqiong, et al.
Publicado: (2021)

Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder
por: Deng, Di, et al.
Publicado: (2021)

Metataxonomic and Metabolic Impact of Fecal Microbiota Transplantation From Patients With Pancreatic Cancer Into Germ-Free Mice: A Pilot Study
por: Genton, Laurence, et al.
Publicado: (2021)

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
por: Ding, Dafa, et al.
Publicado: (2022)

Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity
por: Bibbò, Stefano, et al.
Publicado: (2020)

Effects of Infant Formula Supplemented With Prebiotics and OPO on Infancy Fecal Microbiota: A Pilot Randomized Clinical Trial
por: Zhu, Bingquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dacq4buuv3lul8ja2krgv9775v